Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: February 25, 2026
Reporting Period: Single event date (February 25, 2026)
Business Context: The Company is an emerging growth company incorporated in Delaware, trading on The Nasdaq Stock Market LLC. This filing serves as a Regulation FD disclosure regarding a significant operational milestone.
Key Financial Metrics
This Form 8-K is an event-driven report and does not contain audited financial statements, revenue figures, profit data, cash flow statements, margin analysis, debt levels, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes
The primary material change reported is the successful receipt and deployment of the first shipment of Intelligent Fingerprinting Drug Screening Readers. This shipment was manufactured under a new strategic manufacturing partnership with Syrma Johari MedTech Ltd.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release (Exhibit 99.1) announcing the milestone. The disclosure is qualified in its entirety by the full text of that press release.
Outlook: No specific financial guidance or future projections are included in this filing.
Risks and Contingencies: The filing notes that the information contained in Item 7.01 and Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, nor incorporated by reference unless specifically identified.
Investor Verification Checklist
- Review the full text of the Press Release (Exhibit 99.1) for details on the volume and specifications of the first shipment.
- Verify the terms and financial implications of the strategic manufacturing partnership with Syrma Johari MedTech Ltd.
- Confirm the operational status and deployment timeline of the Intelligent Fingerprinting Drug Screening Readers.
- Check subsequent filings for any financial impact resulting from this manufacturing milestone.